Avalo Therapeutics
AVTX
AVTX
64 hedge funds and large institutions have $223M invested in Avalo Therapeutics in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
27% less call options, than puts
Call options by funds: $264K | Put options by funds: $362K
Holders
64
Holding in Top 10
1
Calls
$264K
Puts
$362K
Top Buyers
| 1 | +$21.1M | |
| 2 | +$5.18M | |
| 3 | +$4.18M | |
| 4 |
Two Sigma Advisers
New York
|
+$2.68M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.67M |
Top Sellers
| 1 | -$4.34M | |
| 2 | -$3.75M | |
| 3 | -$3.38M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.67M |
| 5 |
Renaissance Technologies
New York
|
-$860K |